BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16036106)

  • 1. Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer.
    Bashyam MD; Bair R; Kim YH; Wang P; Hernandez-Boussard T; Karikari CA; Tibshirani R; Maitra A; Pollack JR
    Neoplasia; 2005 Jun; 7(6):556-62. PubMed ID: 16036106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines.
    Heidenblad M; Schoenmakers EF; Jonson T; Gorunova L; Veltman JA; van Kessel AG; Höglund M
    Cancer Res; 2004 May; 64(9):3052-9. PubMed ID: 15126341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of genomic alterations in pancreatic cancer using array-based comparative genomic hybridization.
    Liang JW; Shi ZZ; Shen TY; Che X; Wang Z; Shi SS; Xu X; Cai Y; Zhao P; Wang CF; Zhou ZX; Wang MR
    PLoS One; 2014; 9(12):e114616. PubMed ID: 25502777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
    Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
    Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization.
    Suzuki A; Shibata T; Shimada Y; Murakami Y; Horii A; Shiratori K; Hirohashi S; Inazawa J; Imoto I
    Cancer Sci; 2008 May; 99(5):986-94. PubMed ID: 18380791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome.
    Loukopoulos P; Shibata T; Katoh H; Kokubu A; Sakamoto M; Yamazaki K; Kosuge T; Kanai Y; Hosoda F; Imoto I; Ohki M; Inazawa J; Hirohashi S
    Cancer Sci; 2007 Mar; 98(3):392-400. PubMed ID: 17233815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution characterization of the pancreatic adenocarcinoma genome.
    Aguirre AJ; Brennan C; Bailey G; Sinha R; Feng B; Leo C; Zhang Y; Zhang J; Gans JD; Bardeesy N; Cauwels C; Cordon-Cardo C; Redston MS; DePinho RA; Chin L
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9067-72. PubMed ID: 15199222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
    Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
    Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
    Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
    Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide analysis of pancreatic cancer using microarray-based techniques.
    Harada T; Chelala C; Crnogorac-Jurcevic T; Lemoine NR
    Pancreatology; 2009; 9(1-2):13-24. PubMed ID: 19077451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential gene alteration among hepatoma cell lines demonstrated by cDNA microarray-based comparative genomic hybridization.
    Kawaguchi K; Honda M; Yamashita T; Shirota Y; Kaneko S
    Biochem Biophys Res Commun; 2005 Apr; 329(1):370-80. PubMed ID: 15721316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
    Ruano Y; Mollejo M; Ribalta T; Fiaño C; Camacho FI; Gómez E; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
    Mol Cancer; 2006 Sep; 5():39. PubMed ID: 17002787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification.
    Heidenblad M; Jonson T; Mahlamäki EH; Gorunova L; Karhu R; Johansson B; Höglund M
    Genes Chromosomes Cancer; 2002 Jun; 34(2):211-23. PubMed ID: 11979555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines.
    Gysin S; Rickert P; Kastury K; McMahon M
    Genes Chromosomes Cancer; 2005 Sep; 44(1):37-51. PubMed ID: 15929091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines.
    Giefing M; Arnemann J; Martin-Subero JI; Nieländer I; Bug S; Hartmann S; Arnold N; Tiacci E; Frank M; Hansmann ML; Küppers R; Siebert R
    Br J Haematol; 2008 Sep; 142(6):916-24. PubMed ID: 18671701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
    Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
    J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer.
    Mahlamäki EH; Kauraniemi P; Monni O; Wolf M; Hautaniemi S; Kallioniemi A
    Neoplasia; 2004; 6(5):432-9. PubMed ID: 15548351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization.
    Hurst CD; Fiegler H; Carr P; Williams S; Carter NP; Knowles MA
    Oncogene; 2004 Mar; 23(12):2250-63. PubMed ID: 14968109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.